Simvastatin, but not pravastatin, inhibits the proliferation of esophageal adenocarcinoma and squamous cell carcinoma cells: a cell-molecular study

被引:0
作者
Yan Chen
Li-Bin Li
Jun Zhang
Du-Peng Tang
Jing-Jing Wei
Ze-Hao Zhuang
机构
[1] The First Affiliated Hospital of Fujian Medical University,Department of Endoscopy
[2] The Second Affiliated Hospital of Fujian Medical University,Department of Gastroenterology
[3] The People’s Hospital Affiliated to Fujian University Of Traditional Chinese Medicine,Department of Gastroenterology
来源
Lipids in Health and Disease | / 17卷
关键词
Statin; Esophageal squamous carcinoma cell; Esophageal adenocarcinoma cell; Proliferation;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 116 条
[1]  
Baigent C(2005)Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins Lancet 366 1267-1278
[2]  
Keech A(2008)Statins inhibit proliferation and induce apoptosis in Barrett’s esophageal adenocarcinoma cells Am J Gastroenterol 103 825-837
[3]  
Kearney PM(2011)Barrett’s esophagus: progression to adenocarcinoma and markers Ann N Y Acad Sci 1232 210-229
[4]  
Ogunwobi OO(2013)Statin use is associated with a reduction in the incidence of esophageal adenocarcinoma: a case control study Dis Esophagus 26 838-846
[5]  
Beales IL(2014)Statin use is associated with reduced risk of histologic subtypes of esophageal cancer: a nested case-control analysis Gastroenterology 146 661-668
[6]  
Fang D(2013)Statins are associated with reduced risk of esophageal cancer, particularly in patients with Barrett's esophagus: a systematic review and meta-analysis[J] Clin Gastroenterol Hepatol 11 620-629
[7]  
Das KM(2013)Statin use is associated with a reduction in the incidence of esophageal adenocarcinoma: a case control study Dis Esophagus 26 838-846
[8]  
Cao W(2011)Statin therapy attenuates growth and malignant potential of human esophageal adenocarcinoma cells J Thorac Cardiovasc Surg 142 1152-1160
[9]  
Malhotra U(2011)Oesophageal cancer–an aetiological investigation into the potential protective effect of statins in the UK general practice research database (GPRD) Gastroenterology 140 S-166
[10]  
Triadafilopoulos G(2006)Analysis of five HMG-CoA reductase inhibitors-- atorvastatin, lovastatin, pravastatin, rosuvastatin and simvastatin: pharmacological, pharmacokinetic and analytical overview and development of a new method for use in pharmaceutical formulations analysis and in vitro metabolism studies Biomed Chromatogr 20 282-293